SCHEMBL8407493

SCHEMBL8407493

Cc1cc([N+](=O)[O-])cc2c1CCOO2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.40
TSHR P16473 4/20 0.40
TDP1 Q9NUW8 3/20 0.40
GPR35 Q9HC97 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP19A1 P11511 1/20 0.37
MAPT P10636 2/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
CRHBP P24387 2/20 0.34
CRHR2 Q13324 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
NSD2 O96028 1/20 0.34
LMNA P02545 3/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8407494 0.69 MEN1 (0.45) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL8403277 0.66 ALDH1A1 (0.43) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL6336167 0.66 ALDH1A1 (0.46) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL2105183 0.65 TSHR (0.61) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL27689229 0.65 HTR1D (0.44) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL7484667 0.65 ALDH1A1 (0.42) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL212845 0.64 CYP19A1 (0.81) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL10516379 0.64 ALDH1A1 (0.35) ALDH1A1TSHRTDP1MEN1KMT2A
SCHEMBL8440730 0.63 TSHR (0.58) ALDH1A1TSHRTDP1GPR35CYP3A4
SCHEMBL6378439 0.63 TSHR (0.58) ALDH1A1TSHRTDP1GPR35CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965595-A SIDE EFFECT REDUCTION; TREATING NASAL CONGESTION AND OTHER ALPHA-2 ADRENORECEPTOR MODULATED DISORDERS, WILL NOT CAUSE HYPERTENSION THE PROCTER & GAMBLE COMPANY (US) 1999-10-12 US disclosed
US-5914342-A 2-imidazolinylamino heterocyclic compounds useful as alpha-2 adrenoceptor agonists THE PROCTER & GAMBLE COMPANY (US) 1999-06-22 US disclosed
US-5663189-A RESPIRATORY, EYES, GASTROINTESTINAL THE PROCTER & GAMBLE COMPANY (US) 1997-09-02 US disclosed